BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26738869)

  • 1. Decreased CK1δ expression predicts prolonged survival in colorectal cancer patients.
    Richter J; Rudeck S; Kretz AL; Kramer K; Just S; Henne-Bruns D; Hillenbrand A; Leithäuser F; Lemke J; Knippschild U
    Tumour Biol; 2016 Jul; 37(7):8731-9. PubMed ID: 26738869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of altered expression and activity levels of CK1δ and ɛ on tumor growth and survival of colorectal cancer patients.
    Richter J; Ullah K; Xu P; Alscher V; Blatz A; Peifer C; Halekotte J; Leban J; Vitt D; Holzmann K; Bakulev V; Pinna LA; Henne-Bruns D; Hillenbrand A; Kornmann M; Leithäuser F; Bischof J; Knippschild U
    Int J Cancer; 2015 Jun; 136(12):2799-810. PubMed ID: 25404202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CK1α overexpression correlates with poor survival in colorectal cancer.
    Richter J; Kretz AL; Lemke J; Fauler M; Werner JU; Paschke S; Leithäuser F; Henne-Bruns D; Hillenbrand A; Knippschild U
    BMC Cancer; 2018 Feb; 18(1):140. PubMed ID: 29409464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CK1δ/ε-AES axis regulates tumorigenesis and metastasis in colorectal cancer.
    Wang Z; Zhou L; Wang Y; Peng Q; Li H; Zhang X; Su Z; Song J; Sun Q; Sayed S; Liu S; Lu D
    Theranostics; 2021; 11(9):4421-4435. PubMed ID: 33754069
    [No Abstract]   [Full Text] [Related]  

  • 5. Newly Developed CK1-Specific Inhibitors Show Specifically Stronger Effects on CK1 Mutants and Colon Cancer Cell Lines.
    Liu C; Witt L; Ianes C; Bischof J; Bammert MT; Baier J; Kirschner S; Henne-Bruns D; Xu P; Kornmann M; Peifer C; Knippschild U
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HOTAIR long non-coding RNA is a negative prognostic factor not only in primary tumors, but also in the blood of colorectal cancer patients.
    Svoboda M; Slyskova J; Schneiderova M; Makovicky P; Bielik L; Levy M; Lipska L; Hemmelova B; Kala Z; Protivankova M; Vycital O; Liska V; Schwarzova L; Vodickova L; Vodicka P
    Carcinogenesis; 2014 Jul; 35(7):1510-5. PubMed ID: 24583926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation.
    Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U
    Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OX40 expression enhances the prognostic significance of CD8 positive lymphocyte infiltration in colorectal cancer.
    Weixler B; Cremonesi E; Sorge R; Muraro MG; Delko T; Nebiker CA; Däster S; Governa V; Amicarella F; Soysal SD; Kettelhack C; von Holzen UW; Eppenberger-Castori S; Spagnoli GC; Oertli D; Iezzi G; Terracciano L; Tornillo L; Sconocchia G; Droeser RA
    Oncotarget; 2015 Nov; 6(35):37588-99. PubMed ID: 26439988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-regulation of ncRAN, a long non-coding RNA, contributes to colorectal cancer cell migration and invasion and predicts poor overall survival for colorectal cancer patients.
    Qi P; Xu MD; Ni SJ; Shen XH; Wei P; Huang D; Tan C; Sheng WQ; Zhou XY; Du X
    Mol Carcinog; 2015 Sep; 54(9):742-50. PubMed ID: 24519959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic targeting of casein kinase 1δ in breast cancer.
    Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
    Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CK1δ kinase activity is modulated by protein kinase C α (PKCα)-mediated site-specific phosphorylation.
    Meng Z; Bischof J; Ianes C; Henne-Bruns D; Xu P; Knippschild U
    Amino Acids; 2016 May; 48(5):1185-97. PubMed ID: 26803658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity.
    Kumar A; Rajendran V; Sethumadhavan R; Purohit R
    J Biomol Struct Dyn; 2014; 32(3):394-405. PubMed ID: 23527964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterogeneity analysis of Metastasis Associated in Colon Cancer 1 (MACC1) for survival prognosis of colorectal cancer patients: a retrospective cohort study.
    Koelzer VH; Herrmann P; Zlobec I; Karamitopoulou E; Lugli A; Stein U
    BMC Cancer; 2015 Mar; 15():160. PubMed ID: 25884643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PKA RIα/A-kinase anchoring proteins 10 signaling pathway and the prognosis of colorectal cancer.
    Wang M; Li Y; Wang R; Wang Z; Chen K; Zhou B; Zhou Z; Sun X
    J Gastroenterol Hepatol; 2015 Mar; 30(3):496-503. PubMed ID: 25213315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimized 4,5-Diarylimidazoles as Potent/Selective Inhibitors of Protein Kinase CK1δ and Their Structural Relation to p38α MAPK.
    Halekotte J; Witt L; Ianes C; Krüger M; Bührmann M; Rauh D; Pichlo C; Brunstein E; Luxenburger A; Baumann U; Knippschild U; Bischof J; Peifer C
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28338621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low Expression of DYRK2 (Dual Specificity Tyrosine Phosphorylation Regulated Kinase 2) Correlates with Poor Prognosis in Colorectal Cancer.
    Yan H; Hu K; Wu W; Li Y; Tian H; Chu Z; Koeffler HP; Yin D
    PLoS One; 2016; 11(8):e0159954. PubMed ID: 27532268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
    Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
    Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of kallikrein-related peptidase (KLK10) mRNA expression in colorectal cancer.
    Alexopoulou DK; Papadopoulos IN; Scorilas A
    Clin Biochem; 2013 Oct; 46(15):1453-61. PubMed ID: 23499583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 211 expression is upregulated and associated with poor prognosis in colorectal cancer: a case-control study.
    Sümbül AT; Göğebakan B; Bayram S; Batmacı CY; Öztuzcu S
    Tumour Biol; 2015 Dec; 36(12):9703-9. PubMed ID: 26152286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
    Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
    Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.